These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33570006)

  • 1. Hemodialysis catheter heparin lock related bleeding: Hemorrhagic shock every other day.
    Marques J; Duarte TI; Cotovio P; Borges A; Germano N
    J Vasc Access; 2022 May; 23(3):455-457. PubMed ID: 33570006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium citrate 4% versus heparin as a lock solution in hemodialysis patients with central venous catheters.
    Yon CK; Low CL
    Am J Health Syst Pharm; 2013 Jan; 70(2):131-6. PubMed ID: 23292266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Citrate versus heparin lock for prevention of hemodialysis catheter-related complications: updated systematic review and meta-analysis of randomized controlled trials.
    Mai H; Zhao Y; Salerno S; Li Y; Feng Y; Ma L; Fu P
    Int Urol Nephrol; 2019 Jun; 51(6):1019-1033. PubMed ID: 31012037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized controlled clinical trial of 4% sodium citrate versus heparin as locking solution for temporary dialysis catheters among hemodialysis patients
.
    Abdel Azim ABE; ElSaid TW; El Said HW; Hemida W; Zaghlool S; Ramadan A; Gouda Z; El Masry S; Reda W; Ali HM
    Clin Nephrol; 2018 Nov; 90(5):341-349. PubMed ID: 30148449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.
    Zhao Y; Li Z; Zhang L; Yang J; Yang Y; Tang Y; Fu P
    Am J Kidney Dis; 2014 Mar; 63(3):479-90. PubMed ID: 24125729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy and safety of lock solutions for the prevention of catheter-related complications including infectious and bleeding events in adult haemodialysis patients: a systematic review and network meta-analysis.
    Sheng KX; Zhang P; Li JW; Cheng J; He YC; Böhlke M; Chen JH
    Clin Microbiol Infect; 2020 May; 26(5):545-552. PubMed ID: 31857208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose versus high-dose heparin locks for hemodialysis catheters: a systematic review and meta-analysis.
    Han X; Yang X; Huang B; Yuan L; Cao Y
    Clin Nephrol; 2016 Jul; 86(7):1-8. PubMed ID: 27191662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical application of 4% sodium citrate and heparin in the locking of central venous catheters (excluding dialysis catheters) in intensive care unit patients: A pragmatic randomized controlled trial.
    Deng Y; Xing J; Tan Z; Ai X; Li Y; Zhang L
    PLoS One; 2023; 18(7):e0288117. PubMed ID: 37399185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of heparin to citrate as a catheter locking solution for non-tunneled central venous hemodialysis catheters in patients requiring renal replacement therapy for acute renal failure (VERROU-REA study): study protocol for a randomized controlled trial.
    Bruyère R; Soudry-Faure A; Capellier G; Binquet C; Nadji A; Torner S; Blasco G; Yannaraki M; Barbar SD; Quenot JP
    Trials; 2014 Nov; 15():449. PubMed ID: 25409678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reevaluation of lock solutions for Central venous catheters in hemodialysis: a narrative review.
    Wang Y; Sun X
    Ren Fail; 2022 Dec; 44(1):1501-1518. PubMed ID: 36047812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: a multi-center, controlled, randomized trial.
    Maki DG; Ash SR; Winger RK; Lavin P;
    Crit Care Med; 2011 Apr; 39(4):613-20. PubMed ID: 21200319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients.
    Weijmer MC; van den Dorpel MA; Van de Ven PJ; ter Wee PM; van Geelen JA; Groeneveld JO; van Jaarsveld BC; Koopmans MG; le Poole CY; Schrander-Van der Meer AM; Siegert CE; Stas KJ;
    J Am Soc Nephrol; 2005 Sep; 16(9):2769-77. PubMed ID: 16033861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of locking solutions on conditioning biofilm formation in tunnelled haemodialysis catheters and inflammatory response activation.
    Jiménez Hernández M; Soriano A; Filella X; Calvo M; Coll E; Rebled JM; Poch E; Graterol F; Compte MT; Maduell F; Fontsere N
    J Vasc Access; 2021 May; 22(3):370-379. PubMed ID: 32691665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trisodium citrate: an alternative to unfractionated heparin for hemodialysis catheter dwells.
    Pierce DA; Rocco MV
    Pharmacotherapy; 2010 Nov; 30(11):1150-8. PubMed ID: 20973688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The impact of sodium citrate on dialysis catheter function and frequency of catheter-related bacteriemia and haemorrhage].
    Szymczak M; Weyde W; Penar J; Gołebiowski T; Madziarska K; Krajewska M; Klinger M
    Postepy Hig Med Dosw (Online); 2009 Oct; 63():457-64. PubMed ID: 19837988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cov-hep study: heparin in standard anticoagulation based on citrate for continuous veno-venous hemodialysis in patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.
    Lins PRG; de Albuquerque CCC; Assis CF; Rodrigues BCD; E Siqueira Campos BP; de Oliveira Valle E; Cabrera CPS; de Oliveira Gois J; Segura GC; Strufaldi FL; Mainardes LC; Ribeiro RG; Via Reque Cortes DDP; Lutf LG; de Oliveira MFA; Sales GTM; Smolentzov I; Reichert BV; Andrade L; Seabra VF; Rodrigues CE
    Trials; 2020 Nov; 21(1):920. PubMed ID: 33176886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of taurolidine citrate and unfractionated heparin on inflammatory state and dialysis adequacy in hemodialysis patients.
    Ezzat H; Elsharkawy M; Rezk K; Mohsen R; Mansour A; Emara A
    J Vasc Access; 2023 Jan; 24(1):45-51. PubMed ID: 34112001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locking solutions for hemodialysis catheters; heparin and citrate--a position paper by ASDIN.
    Moran JE; Ash SR;
    Semin Dial; 2008; 21(5):490-2. PubMed ID: 18764795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Taurolidine-Citrate-Heparin Lock Solution Effectively Eradicates Pathogens From the Catheter Biofilm in Hemodialysis Patients.
    Zwiech R; Adelt M; Chrul S
    Am J Ther; 2016; 23(2):e363-8. PubMed ID: 23665885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effectiveness of 30 % trisodium citrate and heparin lock solution in preventing infection and dysfunction of hemodialysis catheters: a randomized controlled trial (CITRIM trial).
    Correa Barcellos F; Pereira Nunes B; Jorge Valle L; Lopes T; Orlando B; Scherer C; Nunes M; Araújo Duarte G; Böhlke M
    Infection; 2017 Apr; 45(2):139-145. PubMed ID: 27573387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.